Text Mining-Based Drug Discovery and MAPK14, STAT3, VEGFA as Novel Candidate Genes in Post-Tuberculosis Tracheobronchial Stenosis.

IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Tohoku Journal of Experimental Medicine Pub Date : 2025-09-27 Epub Date: 2025-03-27 DOI:10.1620/tjem.2025.J028
Wentao Li, Tshetiz Dahal, Guangnan Liu
{"title":"Text Mining-Based Drug Discovery and MAPK14, STAT3, VEGFA as Novel Candidate Genes in Post-Tuberculosis Tracheobronchial Stenosis.","authors":"Wentao Li, Tshetiz Dahal, Guangnan Liu","doi":"10.1620/tjem.2025.J028","DOIUrl":null,"url":null,"abstract":"<p><p>The purpose of this study was to use bioinformatics techniques to investigate the genetic basis and evaluate medication for individuals with Post-Tuberculosis Tracheobronchial Stenosis (PTTS). Text mining was done to find 63 gene sets that are related to tuberculosis, granulation tissue proliferation, cicatrization, and hypertrophic scars. Using the DAVID and STRING tool to study the functional classification of these genes, revealed that these genes are associated with significant ways for instance the 'MAPK' signaling cascade, 'JAK-STAT' signaling pathway, and the 'VEGF' signaling pathway. The relevance of the genes was suggested by real-time quantitative PCR, which verified that MAPK14, STAT3, and VEGFA expression was elevated in PTTS tissues. The 14 hub genes were used to search the DGI database for drugs associated with these genes and the corresponding diseases. Out of the identified compounds, 34 of them were found to be possible drug candidates that could target PTTS's underlying pathophysiology. Such drugs include those targeting protein kinase, a cytokine with anti-inflammatory properties, angiogenesis inhibitors, and those targeting fibrosis. By applying this bioinformatics workflow, it was possible to use very little time in identifying genes and drugs that are involved in the main disease processes of PTTS. Future work should then be directed to conducting more experimental validation on these genes and possible drug candidates for future therapeutic application.</p>","PeriodicalId":23187,"journal":{"name":"Tohoku Journal of Experimental Medicine","volume":" ","pages":"97-109"},"PeriodicalIF":1.6000,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tohoku Journal of Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1620/tjem.2025.J028","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

The purpose of this study was to use bioinformatics techniques to investigate the genetic basis and evaluate medication for individuals with Post-Tuberculosis Tracheobronchial Stenosis (PTTS). Text mining was done to find 63 gene sets that are related to tuberculosis, granulation tissue proliferation, cicatrization, and hypertrophic scars. Using the DAVID and STRING tool to study the functional classification of these genes, revealed that these genes are associated with significant ways for instance the 'MAPK' signaling cascade, 'JAK-STAT' signaling pathway, and the 'VEGF' signaling pathway. The relevance of the genes was suggested by real-time quantitative PCR, which verified that MAPK14, STAT3, and VEGFA expression was elevated in PTTS tissues. The 14 hub genes were used to search the DGI database for drugs associated with these genes and the corresponding diseases. Out of the identified compounds, 34 of them were found to be possible drug candidates that could target PTTS's underlying pathophysiology. Such drugs include those targeting protein kinase, a cytokine with anti-inflammatory properties, angiogenesis inhibitors, and those targeting fibrosis. By applying this bioinformatics workflow, it was possible to use very little time in identifying genes and drugs that are involved in the main disease processes of PTTS. Future work should then be directed to conducting more experimental validation on these genes and possible drug candidates for future therapeutic application.

基于文本挖掘的药物发现和MAPK14, STAT3, VEGFA作为结核后气管支气管狭窄的新候选基因。
本研究的目的是利用生物信息学技术研究结核后气管支气管狭窄(PTTS)患者的遗传基础和药物治疗。文本挖掘找到了63个与结核、肉芽组织增殖、瘢痕和增生性疤痕相关的基因集。利用DAVID和STRING工具研究这些基因的功能分类,发现这些基因与“MAPK”信号级联、“JAK-STAT”信号通路和“VEGF”信号通路等重要途径相关。实时定量PCR证实了MAPK14、STAT3和VEGFA在PTTS组织中的表达升高。使用这14个中心基因在DGI数据库中搜索与这些基因相关的药物和相应的疾病。在鉴定的化合物中,发现其中34种可能是靶向PTTS潜在病理生理的候选药物。这类药物包括靶向蛋白激酶(一种具有抗炎特性的细胞因子)、血管生成抑制剂和靶向纤维化的药物。通过应用这种生物信息学工作流程,可以用很少的时间识别参与PTTS主要疾病过程的基因和药物。未来的工作应该针对这些基因和可能的候选药物进行更多的实验验证,以用于未来的治疗应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.60
自引率
4.50%
发文量
171
审稿时长
1 months
期刊介绍: Our mission is to publish peer-reviewed papers in all branches of medical sciences including basic medicine, social medicine, clinical medicine, nursing sciences and disaster-prevention science, and to present new information of exceptional novelty, importance and interest to a broad readership of the TJEM. The TJEM is open to original articles in all branches of medical sciences from authors throughout the world. The TJEM also covers the fields of disaster-prevention science, including earthquake archeology. Case reports, which advance significantly our knowledge on medical sciences or practice, are also accepted. Review articles, Letters to the Editor, Commentary, and News and Views will also be considered. In particular, the TJEM welcomes full papers requiring prompt publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信